Judit Hajagos-Tóth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Judit Hajagos-Tóth has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Eszter Ducza
Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary
5 shared publications - Róbert Gáspár
Department of Pharmacology and Pharmacotherapy, Szent-Györgyi Albert Faculty of Medicine, University of Szeged, Dom Square 12, H-6720 Szeged, Hungary
5 shared publications - Adrienn Seres
Department of Pharmacodynamics and Biopharmacy, University of Szeged, Szeged, Hungary
2 shared publications - Anna Borsodi
Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Temesvari krt 62, Szeged, H-6726, Hungary
2 shared publications Imre Földesi
2 shared publications- Judit Bóta
Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
2 shared publications
Latest Publications
- Open Access
- 14 June 2016
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 14 (1) , 1-9
The effects of progesterone on the alpha2-adrenergic receptor subtypes in late-pregnant uterine contractions in vitro
The adrenergic system and progesterone play major roles in the control of the uterine function. Our aims were to clarify the changes in function and expression of the α2-adrenergic receptor (AR) subtypes after progesterone pretreatment in late pregnancy. Sprague Dawley rats from pregnancy day 15 were treated with progesterone for 7 days. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blot analysis. In vitro contractions were stimulated with (−)-noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2A). The accumulation of myometrial cAMP was also measured. The activated G-protein level was investigated via GTPγS binding assays. Progesterone pretreatment decreased the contractile effect of (−)-noradrenaline through the α2-ARs. The most significant reduction was found through the α2B-ARs. The mRNA of all of the α2-AR subtypes was increased. Progesterone pretreatment increased the myometrial cAMP level in the presence of BRL 44408 (p < 0.001), spiroxatrine (p < 0.001) or the spiroxatrine + BRL 44408 combination (p < 0.05). Progesterone pretreatment increased the G-protein-activating effect of (−)-noradrenaline in the presence of the spiroxatrine + BRL 44408 combination. The expression of the α2-AR subtypes is progesterone-sensitive. It decreases the contractile response of (−)-noradrenaline through the α2B-AR subtype, blocks the function of α2A-AR subtype and alters the G protein coupling of these receptors, promoting a Gs-dependent pathway. A combination of α2C-AR agonists and α2B-AR antagonists with progesterone could be considered for the treatment or prevention of preterm birth.
- 14 June 2016
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 14 (1) , 1-9
Open AccessThe effects of progesterone on the alpha2-adrenergic receptor subtypes in late-pregnant uterine contractions in vitro
The adrenergic system and progesterone play major roles in the control of the uterine function. Our aims were to clarify the changes in function and expression of the α2-adrenergic receptor (AR) subtypes after progesterone pretreatment in late pregnancy. Sprague Dawley rats from pregnancy day 15 were treated with progesterone for 7 days. The myometrial expressions of the α2-AR subtypes were determined by RT-PCR and Western blot analysis. In vitro contractions were stimulated with (−)-noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A), ARC 239 (α2B/C) and spiroxatrine (α2A). The accumulation of myometrial cAMP was also measured. The activated G-protein level was investigated via GTPγS binding assays. Progesterone pretreatment decreased the contractile effect of (−)-noradrenaline through the α2-ARs. The most significant reduction was found through the α2B-ARs. The mRNA of all of the α2-AR subtypes was increased. Progesterone pretreatment increased the myometrial cAMP level in the presence of BRL 44408 (p < 0.001), spiroxatrine (p < 0.001) or the spiroxatrine + BRL 44408 combination (p < 0.05). Progesterone pretreatment increased the G-protein-activating effect of (−)-noradrenaline in the presence of the spiroxatrine + BRL 44408 combination. The expression of the α2-AR subtypes is progesterone-sensitive. It decreases the contractile response of (−)-noradrenaline through the α2B-AR subtype, blocks the function of α2A-AR subtype and alters the G protein coupling of these receptors, promoting a Gs-dependent pathway. A combination of α2C-AR agonists and α2B-AR antagonists with progesterone could be considered for the treatment or prevention of preterm birth.
- 1 December 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 769, 177-184
The effects of female sexual hormones on the expression and function of α1A- and α1D-adrenoceptor subtypes in the late-pregnant rat myometrium
- 1 December 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 769, 177-184
The effects of female sexual hormones on the expression and function of α1A- and α1D-adrenoceptor subtypes in the late-pregnant rat myometrium
- 1 April 2014
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 153 (2) , 446-453
Androgenic effect of honeybee drone milk in castrated rats: Roles of methyl palmitate and methyl oleate
- 1 April 2014
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 153 (2) , 446-453
Androgenic effect of honeybee drone milk in castrated rats: Roles of methyl palmitate and methyl oleate
- 1 January 2014
- Vol. 84 (3) , 111-9
[The effect of R(+) limonene on β-adrenergic signaling in smooth muscles: the significance of oxidative stress index].
Reactive oxygen intermediers (ROI) play a role in the signal transduction of beta-adrenergic receptors. We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (β2-AR)-regulated smooth muscles. Tissue samples were collected from nonpregnant (trachea) and 22-day-pregnant (myometrium and cervix) rats. Tissue contractility was investigated in an isolated organ bath. In separate groups of animals, the tracheal and uterine β2-AR activities were upregulated by 17-beta-estradiol valerate (E2) and progesterone (P4), respectively. The total oxidant (TOS) and total antioxidant status (TAS) were also measured. The oxidative stress index (OSI) was defined as the ratio ofTOS and TAS. Terbutaline (10(-10) - 10(-5) M) decreased the spontaneous contractions in the nontreated and the P4-pretreated myometria. The concentration-response curves for terbutaline in the presence of 10-3 M limonene were shifted to the left, but the maximum inhibitory effect was unchanged. Terbutaline (10(-6) M) increased the cervical resistance both in the nontreated and in the P4-treated samples, while limonene reduced this action only in the P4-treated cervices. Terbutaline (10(-9) - 10(-4) M) reduced the tracheal tones both in the nontreated and in the E2-treated tissues, while limonene reduced these effects. The OSI was highest in the trachea and lowest in the pregnant myometrium. Limonene has various influence on terbutaline induced effects in certain tissues. Higher OSI value means, that the antioxidants have greater role in the beta-adrenergic signalmechanism. We assume that the significance of ROI in the signalling process of the β2-ARs are divergent in the various tissues. Our results suggest that the antiasthmatic effect of beta-mimetics may worsen during parallel limonene administration.
- 1 January 2014
- Vol. 84 (3) , 111-9
[The effect of R(+) limonene on β-adrenergic signaling in smooth muscles: the significance of oxidative stress index].
Reactive oxygen intermediers (ROI) play a role in the signal transduction of beta-adrenergic receptors. We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (β2-AR)-regulated smooth muscles. Tissue samples were collected from nonpregnant (trachea) and 22-day-pregnant (myometrium and cervix) rats. Tissue contractility was investigated in an isolated organ bath. In separate groups of animals, the tracheal and uterine β2-AR activities were upregulated by 17-beta-estradiol valerate (E2) and progesterone (P4), respectively. The total oxidant (TOS) and total antioxidant status (TAS) were also measured. The oxidative stress index (OSI) was defined as the ratio ofTOS and TAS. Terbutaline (10(-10) - 10(-5) M) decreased the spontaneous contractions in the nontreated and the P4-pretreated myometria. The concentration-response curves for terbutaline in the presence of 10-3 M limonene were shifted to the left, but the maximum inhibitory effect was unchanged. Terbutaline (10(-6) M) increased the cervical resistance both in the nontreated and in the P4-treated samples, while limonene reduced this action only in the P4-treated cervices. Terbutaline (10(-9) - 10(-4) M) reduced the tracheal tones both in the nontreated and in the E2-treated tissues, while limonene reduced these effects. The OSI was highest in the trachea and lowest in the pregnant myometrium. Limonene has various influence on terbutaline induced effects in certain tissues. Higher OSI value means, that the antioxidants have greater role in the beta-adrenergic signalmechanism. We assume that the significance of ROI in the signalling process of the β2-ARs are divergent in the various tissues. Our results suggest that the antiasthmatic effect of beta-mimetics may worsen during parallel limonene administration.
- 1 January 2014
- Vol. 84 (3) , 111-9
[The effect of R(+) limonene on β - adrenerg signaling: the significance of oxidative stress index].
Reactive oxygen intermediers (ROI) play a role in the signal transduction of beta-adrenergic receptors. We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (β2-AR)-regulated smooth muscles. Tissue samples were collected from nonpregnant (trachea) and 22-day-pregnant (myometrium and cervix) rats. Tissue contractility was investigated in an isolated organ bath. In separate groups of animals, the tracheal and uterine β2-AR activities were upregulated by 17-beta-estradiol valerate (E2) and progesterone (P4), respectively. The total oxidant (TOS) and total antioxidant status (TAS) were also measured. The oxidative stress index (OSI) was defined as the ratio ofTOS and TAS. Terbutaline (10(-10) - 10(-5) M) decreased the spontaneous contractions in the nontreated and the P4-pretreated myometria. The concentration-response curves for terbutaline in the presence of 10-3 M limonene were shifted to the left, but the maximum inhibitory effect was unchanged. Terbutaline (10(-6) M) increased the cervical resistance both in the nontreated and in the P4-treated samples, while limonene reduced this action only in the P4-treated cervices. Terbutaline (10(-9) - 10(-4) M) reduced the tracheal tones both in the nontreated and in the E2-treated tissues, while limonene reduced these effects. The OSI was highest in the trachea and lowest in the pregnant myometrium. Limonene has various influence on terbutaline induced effects in certain tissues. Higher OSI value means, that the antioxidants have greater role in the beta-adrenergic signalmechanism. We assume that the significance of ROI in the signalling process of the β2-ARs are divergent in the various tissues. Our results suggest that the antiasthmatic effect of beta-mimetics may worsen during parallel limonene administration.
- 1 January 2014
- Vol. 84 (3) , 111-9
[The effect of R(+) limonene on β - adrenerg signaling: the significance of oxidative stress index].
Reactive oxygen intermediers (ROI) play a role in the signal transduction of beta-adrenergic receptors. We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (β2-AR)-regulated smooth muscles. Tissue samples were collected from nonpregnant (trachea) and 22-day-pregnant (myometrium and cervix) rats. Tissue contractility was investigated in an isolated organ bath. In separate groups of animals, the tracheal and uterine β2-AR activities were upregulated by 17-beta-estradiol valerate (E2) and progesterone (P4), respectively. The total oxidant (TOS) and total antioxidant status (TAS) were also measured. The oxidative stress index (OSI) was defined as the ratio ofTOS and TAS. Terbutaline (10(-10) - 10(-5) M) decreased the spontaneous contractions in the nontreated and the P4-pretreated myometria. The concentration-response curves for terbutaline in the presence of 10-3 M limonene were shifted to the left, but the maximum inhibitory effect was unchanged. Terbutaline (10(-6) M) increased the cervical resistance both in the nontreated and in the P4-treated samples, while limonene reduced this action only in the P4-treated cervices. Terbutaline (10(-9) - 10(-4) M) reduced the tracheal tones both in the nontreated and in the E2-treated tissues, while limonene reduced these effects. The OSI was highest in the trachea and lowest in the pregnant myometrium. Limonene has various influence on terbutaline induced effects in certain tissues. Higher OSI value means, that the antioxidants have greater role in the beta-adrenergic signalmechanism. We assume that the significance of ROI in the signalling process of the β2-ARs are divergent in the various tissues. Our results suggest that the antiasthmatic effect of beta-mimetics may worsen during parallel limonene administration.
- Open Access
- 23 May 2013
- Published by MDPI AG in Pharmaceuticals
- Vol. 6 (6) , 689-699
Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Dihydropyridine Ca2+ channel blockers (CCBs) are widely accepted in the treatment of premature labour. Their mechanism of action in tocolysis involves the blockade of L-type Ca2+ channels, influenced by the Ca2+-activated K+ channels, beta-adrenergic receptors (β-ARs) and sexual hormones. In clinical practice, most experience has been gained with the use of nifedipine, whose efficacy is superior or comparable to those of β-agonists and oxytocin antagonists. Additionally, it has a favourable adverse effect profile as compared with the majority of other tocolytics. The most frequent and well-tolerated side-effects of CCBs are tachycardia, headache and hypotension. In tocolytic therapy efforts are currently being made to find combinations of tocolytic agents that yield better therapeutic action. The available human and animal studies suggest that the combination of CCBs with β-AR agonists is beneficial, although such combinations can pose risk of pulmonary oedema in multiple pregnancies and maternal cardiovascular diseases. Preclinical data indicate the potential benefit of combinations of CCBs and oxytocin antagonists. However, the combinations of CCBs with progesterone or cyclooxygenase inhibitors may decrease their efficacy. The CCBs are likely to remain one of the most important groups of drugs for the rapid inhibition of premature uterine contractions. Their significance may be magnified by further clinical studies on their combined use for tocolysis.
- 23 May 2013
- Published by MDPI AG in Pharmaceuticals
- Vol. 6 (6) , 689-699
Open AccessCalcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Dihydropyridine Ca2+ channel blockers (CCBs) are widely accepted in the treatment of premature labour. Their mechanism of action in tocolysis involves the blockade of L-type Ca2+ channels, influenced by the Ca2+-activated K+ channels, beta-adrenergic receptors (β-ARs) and sexual hormones. In clinical practice, most experience has been gained with the use of nifedipine, whose efficacy is superior or comparable to those of β-agonists and oxytocin antagonists. Additionally, it has a favourable adverse effect profile as compared with the majority of other tocolytics. The most frequent and well-tolerated side-effects of CCBs are tachycardia, headache and hypotension. In tocolytic therapy efforts are currently being made to find combinations of tocolytic agents that yield better therapeutic action. The available human and animal studies suggest that the combination of CCBs with β-AR agonists is beneficial, although such combinations can pose risk of pulmonary oedema in multiple pregnancies and maternal cardiovascular diseases. Preclinical data indicate the potential benefit of combinations of CCBs and oxytocin antagonists. However, the combinations of CCBs with progesterone or cyclooxygenase inhibitors may decrease their efficacy. The CCBs are likely to remain one of the most important groups of drugs for the rapid inhibition of premature uterine contractions. Their significance may be magnified by further clinical studies on their combined use for tocolysis.
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Tocopherol interacts with [b]-mimetic effect in reproductive and respiratory tracts in the rat
Background: It is known that reactive oxygen species (ROS) production is necessary for the signal transduction mechanism of β-adrenergic receptors. Aim: Our aim was to investigate whether antioxidant agent (α)-tocopherol-acid-succinate may reduce the effect of β-mimetic action on β(2)-adrenergic receptor regulated tissues. Methods: Tissue samples were collected from non-pregnant (trachea) and 22-day pregnant (myometrium, cervix) rats. In separated groups of animals, the tracheal and uterine β-adrenoceptor activities were upregulated by 17-β-oestradiol-valerate and progesterone treatment, respectively. Cervical resistance, myometrial and tracheal contractions were investigated in isolated organ bath. The cyclic AMP accumulations in the tissues were measured with competitive cyclic AMP Enzyme Immunoassay (EIA) Kit. Results: Terbutaline (10−6 M) increased the cervical resistance both in non-treated and progesterone-treated samples. Tocopherol (10−7 M) reduced this action in progesterone-treated samples, but had no effect on non-treated cervices. Terbutaline (10−10 to 10−5 M) decreased the spontaneous myometrial contraction both in non-treated and progesterone-treated tissues. The presence of tocopherol did not alter this action in any cases. Terbutaline (10−9 to 10−4 M) reduced the tracheal tones both in non-treated and oestrogen-treated tissues. This effect was reduced by tocopherol in both cases (by 52% in non-treated and 68% in oestrogen-treated tissues). The changes in tissues cAMP levels showed a strong correlation with the isolated organ results. Conclusions: Tocopherol as a free radical scavenger may interact with the β-mimetic action. This effect is pronounced in trachea, slight in the cervix and non-significant in the myometrium. These results suggest that the ROS may have different significance in the signalling process of β(2)-adrenergic receptors in different tissues.
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Tocopherol interacts with [b]-mimetic effect in reproductive and respiratory tracts in the rat
Background: It is known that reactive oxygen species (ROS) production is necessary for the signal transduction mechanism of β-adrenergic receptors. Aim: Our aim was to investigate whether antioxidant agent (α)-tocopherol-acid-succinate may reduce the effect of β-mimetic action on β(2)-adrenergic receptor regulated tissues. Methods: Tissue samples were collected from non-pregnant (trachea) and 22-day pregnant (myometrium, cervix) rats. In separated groups of animals, the tracheal and uterine β-adrenoceptor activities were upregulated by 17-β-oestradiol-valerate and progesterone treatment, respectively. Cervical resistance, myometrial and tracheal contractions were investigated in isolated organ bath. The cyclic AMP accumulations in the tissues were measured with competitive cyclic AMP Enzyme Immunoassay (EIA) Kit. Results: Terbutaline (10−6 M) increased the cervical resistance both in non-treated and progesterone-treated samples. Tocopherol (10−7 M) reduced this action in progesterone-treated samples, but had no effect on non-treated cervices. Terbutaline (10−10 to 10−5 M) decreased the spontaneous myometrial contraction both in non-treated and progesterone-treated tissues. The presence of tocopherol did not alter this action in any cases. Terbutaline (10−9 to 10−4 M) reduced the tracheal tones both in non-treated and oestrogen-treated tissues. This effect was reduced by tocopherol in both cases (by 52% in non-treated and 68% in oestrogen-treated tissues). The changes in tissues cAMP levels showed a strong correlation with the isolated organ results. Conclusions: Tocopherol as a free radical scavenger may interact with the β-mimetic action. This effect is pronounced in trachea, slight in the cervix and non-significant in the myometrium. These results suggest that the ROS may have different significance in the signalling process of β(2)-adrenergic receptors in different tissues.
- 1 October 2009
- Published by Elsevier in Life Sciences
- Vol. 85 (15-16) , 568-572
Modification of the effect of nifedipine in the pregnant rat myometrium: The influence of progesterone and terbutaline
- 1 October 2009
- Published by Elsevier in Life Sciences
- Vol. 85 (15-16) , 568-572
Modification of the effect of nifedipine in the pregnant rat myometrium: The influence of progesterone and terbutaline